Clinical Study
Feasibility and Safely of Oral Rehydration Therapy before Upper Gastrointestinal Endoscopic Submucosal Dissection
| | PORT (120) | Non-PORT (120) | value |
| | Age () | | | 0.47 | | Sex (male, female) | 93, 27 | 90, 30 | 0.71 | | Hematocrit before admission (, %) | | | 0.85 | | Comorbidity for Charlson’s score () | | | 0.57 | | Myocardial infarction | 5 | 6 | 0.76 | | Cerebral infarction | 3 | 3 | 1 | | Diabetic mellitus | 10 | 12 | 0.66 | | Chronic kidney disease | 4 | 5 | 0.73 | | Antithrombotic therapy | 8 | 10 | 0.62 | | Location (esophagus, stomach, and duodenum) | 39, 79, 2 | 44, 76, 0 | 0.48 |
|
|
PORT: preoperative oral rehydration therapy; SD: standard deviation.
|